BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4333497)

  • 21. Specific transplantation resistance against mouse tumour induced by Mouse Sarcoma Virus (Harvey).
    Koldovský P; Turano A; Fadda G
    Folia Biol (Praha); 1969; 15(3):224-5. PubMed ID: 4307791
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor-induced skin heterogenization. I. Reciprocal relationship between tumors and skin grafts.
    Mkheidze DM; Liozner AL; Svet-Moldavsky GJ
    J Natl Cancer Inst; 1970 Sep; 45(3):465-73. PubMed ID: 4331640
    [No Abstract]   [Full Text] [Related]  

  • 23. An anemia-inducing virus derived from tumors caused by murine sarcoma virus--Moloney.
    Taylor DO; Cremer NE; Oshiro LS; Lennette EH
    J Natl Cancer Inst; 1972 Sep; 49(3):829-45. PubMed ID: 4345969
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumors and other lesions induced by murine sarcoma viruses.
    Chesterman FC; Harvey JJ; Branca M; Phillips DE; Hallowes RC; Bassin RH
    Prog Exp Tumor Res; 1972; 16():426-53. PubMed ID: 4339212
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of carcinogenesis by murine sarcoma virus (Harvey) following injections of immune sera during the latent period.
    Bubeník J; Turano A; Fadda G
    Int J Cancer; 1969 Sep; 4(5):648-54. PubMed ID: 4310638
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the growth and regression of a transplantable Moloney sarcoma.
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 Nov; 27(11):2207-11. PubMed ID: 4864248
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of the graft-versus-host reaction on transplantation immunity to homologous tumors].
    Semenkov VF; Shevelev AS
    Vopr Onkol; 1971; 17(6):69-73. PubMed ID: 4400328
    [No Abstract]   [Full Text] [Related]  

  • 28. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 29. Naturally occurring sarcoma virus of the BALB/cCr mouse.
    Peters RL; Rabstein LS; VanVleck R; Kelloff GJ; Huebner RJ
    J Natl Cancer Inst; 1974 Dec; 53(6):1725-9. PubMed ID: 4373578
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 31. Host response to premalignant mammary tissues.
    Slemmer G
    Natl Cancer Inst Monogr; 1972 Dec; 35():57-71. PubMed ID: 4659058
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of the immune response to antigenic tumors in isogenic mice by whole-body irradiation.
    Rosenau W; Moon HD
    Cancer Res; 1967 Nov; 27(11):1973-81. PubMed ID: 6073496
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor-induced skin heterogenization. 3. Immunologic and immunogenetic mechanisms.
    Liozner AL; Svet-Moldavsky GJ; Mkheidze DM
    J Natl Cancer Inst; 1970 Sep; 45(3):485-94. PubMed ID: 4943065
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-bound immune reactions against tumor specific transplantation antigens.
    Hellström IE; Hellström KE; Pierce GE
    Proc Can Cancer Conf; 1969; 8():425-42. PubMed ID: 4307358
    [No Abstract]   [Full Text] [Related]  

  • 36. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.
    Gorczynski RM
    J Immunol; 1974 Feb; 112(2):533-9. PubMed ID: 4360545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.